Thoracic Catheters Market Size, Share, Regional Growth, 2026-2034

Market Overview

According to fortune business insights, The global thoracic catheters market size was valued at USD 285.9 million in 2025. The market is projected to grow from USD 311.8 million in 2026 to USD 399.0 million by 2034, exhibiting a CAGR of 3.7% during the forecast period. North America dominated the thoracic catheters market with a market share of 36.31% in 2025.

The analysis shows that top companies such as Teleflex Incorporated, Getinge AB, BD, and Cardinal Health are investing in strategic initiatives as hospitals manage a steady stream of thoracic surgeries and emergency admissions. This trend indicates a strong demand for reliable drainage solutions that are easier to place and compatible with modern post-operative pathways.

Major Players Profiled in the Market Report:

• Teleflex Incorporated (U.S.)

• Getinge AB (Sweden)

• BD (U.S.)

• Cardinal Health (U.S.)

• Cook Medical (U.S.)

• Braun (Germany)

• Medela (Switzerland)

• Vygon (France)

• Poly Medicure Ltd. (India)

• Redax S.p.A. (Italy)

Segments

Wide Adoption in Several Applications to Drive Chest Drainage Catheters Segment Growth

Based on product type, the market is segmented into chest drainage catheters, pleural drainage catheters, thoracic suction catheters, thoracostomy catheters, and others. The chest drainage catheters segment holds the highest share as they are the default option across a broad range of high-volume scenarios, especially post-operative thoracic drainage and acute trauma cases.

Silicone Dominates as Comfort and Flexibility Support Longer Dwell Time

By material, the market is classified into silicone, polyurethane, PVC, and others. The silicone segment holds the largest market share as it performs well in clinical situations where patient comfort, flexibility, and biocompatibility matter, making it preferred for longer dwell times.

Post-operative Thoracic Drainage Leads Due to Routine Surgical Protocols

Based on application, the market is classified into pleural effusion, pneumothorax, hemothorax, empyema, post-operative thoracic drainage, and others. The post-operative thoracic drainage segment holds the largest share as drainage is a routine, non-optional part of management after many cardiothoracic procedures.

Hospitals and ASCs to Dominate the Market Due to High Procedure Volume

Based on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others. The hospitals & ASCs segment holds the largest market share as most thoracic catheter placements occur in settings equipped for surgery and high-acuity care, such as operating rooms, ICUs, and emergency departments.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Source: https://www.fortunebusinessinsights.com/thoracic-catheters-market-115836

Report Coverage

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players.

• The latest industry developments include product launches, partnerships, mergers, and acquisitions.

Drivers & Restraints

Rising Procedure Volume and Standardized Post-operative Care to Fuel Market Growth

A significant factor driving market growth is the predictable need for pleural and chest drainage across a wide set of clinical pathways, including cardiothoracic surgeries and emergency trauma care. As hospitals push for standardized recovery protocols to improve safety, efficiency, and outcomes, the demand for reliable and effective thoracic catheters increases.

However, hospitals expect strong reliability but also demand aggressive pricing, especially for high-volume products. As group purchasing and centralized procurement expand, suppliers face tighter contract terms, which may hamper market growth.

Regional Insights

High Volume of Surgeries in the U.S. Propels Market Growth in North America

North America holds the dominant thoracic catheters market share. The region’s growth is anchored in its consistently high volume of cardiothoracic surgeries, trauma care, and ICU admissions, where chest drainage is a routine part of post-operative and emergency management.

Asia Pacific is one of the fastest-growing regions in the market. The growth is attributed to rising procedure access, expanding hospital capacity, improving emergency care systems, and greater adoption of procedural best practices in the region.

Thoracic Catheters Market Future Growth:

The thoracic catheters market is experiencing robust growth, fueled by rising procedure volumes and an emphasis on improving patient pathways. Today's clinicians are increasingly drawn to more tailored catheter choices by indication and care setting, favoring smaller-bore catheters and pigtail-style options that improve patient comfort and mobility. Additionally, there is a growing interest in specialized pleural drainage catheters that support outpatient management for conditions like recurrent pleural effusion. The rapid expansion of hospital capacity in emerging markets and a focus on reducing complications and hospital stays are also key growth drivers. While North America continues to dominate due to high surgical volumes, the Asia-Pacific region is seeing a surge in demand as access to advanced surgical care expands.

Competitive Landscape

Robust Product Innovation to Reinforce the Market Position of Prominent Players

The market features prominent players like Teleflex Incorporated, Getinge AB, BD, and Cardinal Health. These leading companies are accelerating growth through strategic initiatives such as robust product innovation, brand enhancement through broad portfolios, and maintaining contracted supply relationships with large health systems. Their proactive approach to meeting clinical demands for reliability and improved outcomes continues to fuel the market’s momentum.

Key Industry Development

• July 2025: Teleflex Incorporated, a leading global provider of medical technologies, completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG.

• August 2024: Getinge announced that it had agreed to acquire Paragonix Technologies, Inc., a leading U.S. company in organ transport products and services.